N = 187 | Benign | Borderline | Malignant |
---|---|---|---|
Prevalence | 33.2% (26.5–40.4%) | 12.8% (8.4–18.5%) | 54.0% (46.6–61.3%) |
Sensitivity | 98.4% (91.3–99.9%) | 75.0% (53.2–90.2%) | 88.1% (80.2–93.7%) |
Sensitivity | 93.6% (87.7–97.2%) | 95.1% (90.6–97.9%) | 98.8% (93.7–99.9%) |
PPV | 88.4% (79.6–93.2%) | 69.2% (52.4–82.1%) | 98.9% (92.7–99.8%) |
NPV | 99.2% (94.4–99.8%) | 96.3% (92.8–98.1%) | 87.6% (80.6–92.4%) |